At a hearing last month in the multidistrict litigation over Zantac, plaintiffs lawyer Mikal Watts praised the use of a registry that now has collected 140,000 claims from individuals insisting the heartburn medication caused them to get cancer.

The claims far exceed the 828 lawsuits pending over Zantac as of Sept. 15, according to statistics from the U.S. Judicial Panel on Multidistrict Litigation. But the registry is a way for U.S. District Judge Robin Rosenberg, who is overseeing the Zantac multidistrict litigation in West Palm Beach, Florida, to keep track of the claims that are out there—whether they are filed or not.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]